"Complejo Hospitalario Universitario A Coruna (CHUAC)"
Welcome,         Profile    Billing    Logout  
 2 Trials 
11 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Campelo, Rosario García
ZEAL-1L, NCT04475939 / 2020-002202-20: Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer

Checkmark [VIRTUAL] First-line (1L Maintenance Therapy with Niraparib (nira + Pembrolizumab (pembro vs Placebo + Pembro in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC: Phase 3 ZEAL-1L Study
Checkmark JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer.
Checkmark [VIRTUAL] First-line (1L) maintenance therapy with niraparib (nira) + pembrolizumab (pembro) vs placebo + pembro in advanced/metastatic non-small cell lung cancer (NSCLC): Phase III ZEAL-1L study
Checkmark Niraparib (Nira) + pembrolizumab (Pembro) versus placebo (PBO) + Pembro 1L maintenance therapy in advanced non-small cell lung cancer (NSCLC): ZEAL-1L phase 3 study
Recruiting
3
650
Europe, US, RoW
Niraparib, Pembrolizumab, Placebo
GlaxoSmithKline
Lung Cancer, Non-Small Cell
08/24
10/24
NADIM-ADJUVANT, NCT04564157: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Checkmark [VIRTUAL] A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.
Recruiting
3
210
Europe
Carboplatin, ATC code: L01XA02, Paclitaxel, ATC code: L01CD01, Nivolumab, ATC code: L01XC17
Fundación GECP
Non-Small Cell Lung Cancer, Adjuvant Chemotherapy
04/27
04/28
COSTAR Lung, NCT04655976 / 2020-003433-37: Study of Cobolimab in Combination With Dostarlimab and Docetaxel in Advanced NSCLC Participants

Recruiting
2/3
250
Europe, Canada, US, RoW
Cobolimab, Dostarlimab, Docetaxel
GlaxoSmithKline, GlaxoSmithKline Research and Devlopment Limited, GlaxoSmithKline Research and Development Limited
Lung Cancer, Non-Small Cell
09/24
01/26
Replay, NCT03526887: Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC

Recruiting
2
110
Europe
Pembrolizumab
Spanish Lung Cancer Group
Lung Cancer
07/22
07/23
ABC-lung, NCT04245085 / 2019-001687-30: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma

Recruiting
2
95
Europe, RoW
Atezolizumab, Tecentriq, Bevacizumab, Avastin, Carboplatin, Paclitaxel, Pemetrexed, Alimta
European Thoracic Oncology Platform, Roche Pharma AG
EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
12/22
03/23
GECP 20/01_Neo-DIANA, NCT04512430: Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Recruiting
2
26
Europe
Atezolizumab, Bevacizumab, Carboplatin, Pemetrexed
Fundación GECP
Non-Small Cell Lung Cancer, Positive for Epidermal Growth Factor Receptor Expression
08/23
08/26
BIMES, NCT05005429 / 2020-004902-67: Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma

Not yet recruiting
2
47
Europe
Bintrafusp alfa, M7824
Fundación GECP, Fundación GECP
Mesothelioma; Lung
03/25
04/25
NIVIPI-Brain, NCT05012254: Study of Nivolumab and Ipilimumab Plus Chemotherapy as a Treatment for Patients With Stage IV Lung Cancer With Brain Metastases

Not yet recruiting
2
71
Europe
Ipilimumab, Nivolumab, Carboplatin, Cisplatin, Cis-diamminedichloroplatinum, Paclitaxel, Pemetrexed, Pemetrexed disodium; ALIMTA
Fundación GECP
Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer
03/26
12/26
APOLO, NCT04776447 / 2020-004459-33: Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy.

Recruiting
2
51
Europe
Carboplatin, Carboplatinum, Placlitaxel, Taxol, Atezolizumab, Tecentriq
Fundación GECP, Fundación GECP
Lung Diseases, Carcinoma, Non-Small-Cell Lung, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Respiratory Tract Neoplasms, Carcinoma Bronchiogenic Stage III, Thoracic Neoplasms
11/26
11/27
GRAVID, NCT04344002: LunG and Melanoma canceR pAtients coVId19 Disease

Recruiting
N/A
200
Europe
Spanish Lung Cancer Group
Covid-19, Lung Cancer
03/22
10/22
NCT02941458: Thoracic Tumours Register

Checkmark Tobacco use in lung cancer (LC) patients (p) in Spain
Checkmark Biomarker testing of lung cancer in Spain
Checkmark Spanish registry of thoracic tumors (TTR): Interim analyses of comorbidities, risk associations, personal and family history of cancer
Checkmark [VIRTUAL] Clinical characteristics and survival in stage I-IIIA lung cancer resected patients in Spain, analyzed in the Thoracic Tumors Registry (TTR)
Recruiting
N/A
10000
Europe
Spanish Lung Cancer Group
Thoracic Tumors
12/25
12/30

Download Options